The 36-month beta value for CHEK is at 0.27. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CHEK is 4.38M, and currently, shorts hold a 1.10% of that float. The average trading volume for CHEK on May 15, 2025 was 190.69K shares.
CHEK) stock’s latest price update
Check-Cap Ltd (NASDAQ: CHEK)’s stock price has gone rise by 8.30 in comparison to its previous close of 0.90, however, the company has experienced a -1.02% decrease in its stock price over the last five trading days. prnewswire.com reported 2025-05-14 that Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board’s and Management Team’s Destruction of 99% of Stock’s Value, Costing Shareholders $1 Billion Conference Call is a Blatant, Self-Serving Reaction by a Management Team Running Scared Following Apollo Capital’s Intention to Nominate Six Highly Qualified Directors to MediPharm’s Board Shareholders Deserve Answers From Management About Massive Underperformance, Failed Operational Strategies, Poor Capital Allocation, Outrageous Compensation, and Lack of Transparency Apollo Capital’s Nominees Bring Significant Turnaround, M&A, and Operational Experience in Cannabis and Adjacent Industries, and Will Execute Plan to Restore Value for ALL MediPharm Shareholders Urges MediPharm Shareholders to Vote for Wholesale Change at Annual Meeting TORONTO, May 14, 2025 /PRNewswire/ — Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3.0% of the Company’s common stock, today posed several critical questions that shareholders should ask MediPharm management on this morning’s conference call following its first quarter 2025 earnings report. CEO David Pidduck and his management team have not held a call with shareholders since the second quarter of 2024 to avoid having to defend themselves after destroying 99% of the value of the company’s stock, or nearly $1 billion.
CHEK’s Market Performance
CHEK’s stock has fallen by -1.02% in the past week, with a monthly rise of 48.55% and a quarterly rise of 12.23%. The volatility ratio for the week is 26.12% while the volatility levels for the last 30 days are 16.39% for Check-Cap Ltd The simple moving average for the past 20 days is 22.77% for CHEK’s stock, with a -16.42% simple moving average for the past 200 days.
Analysts’ Opinion of CHEK
H.C. Wainwright, on the other hand, stated in their research note that they expect to see CHEK reach a price target of $6, previously predicting the price at $5.50. The rating they have provided for CHEK stocks is “Buy” according to the report published on January 11th, 2018.
H.C. Wainwright gave a rating of “Buy” to CHEK, setting the target price at $5.50 in the report published on November 28th of the previous year.
CHEK Trading at 24.83% from the 50-Day Moving Average
After a stumble in the market that brought CHEK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.09% of loss for the given period.
Volatility was left at 16.39%, however, over the last 30 days, the volatility rate increased by 26.12%, as shares surge +41.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.80% upper at present.
During the last 5 trading sessions, CHEK fell by -1.02%, which changed the moving average for the period of 200-days by -51.74% in comparison to the 20-day moving average, which settled at $0.7901. In addition, Check-Cap Ltd saw -2.01% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CHEK
The total capital return value is set at -0.63.
Currently, EBITDA for the company is -17.65 million with net debt to EBITDA at 1.69.
Conclusion
In conclusion, Check-Cap Ltd (CHEK) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
